Is Vincerx Pharma Inc (NASDAQ: VINC) Still On The Rise?

After Hours

There is a slight risk associated with trading before and after the market open. Due to lower liquidity and higher volatility, extended-hours trading may result in wider spreads on particular security due to the release of critical financial information after regular trading hours. Yahoo Finance discussed the stock recently as it posted Vincerx to Host Virtual Investor Event Reviewing Preliminary Phase 1 VIP236 Data Presented at the American Association for Cancer Research (AACR) Annual Meeting 2024.

Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.

Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!

Get the FREE Report with all the details here.


Stocks Info

This NASDAQ-listed company operates within the Biotechnology industry segment, falling under the Healthcare sector. The current market capitalization of Vincerx Pharma Inc is $136.19M. A total of 0.71 million shares were traded on the day, compared to an average of 1.09M shares.

In the most recent transaction, Seelenberger Alexander A. bought 10,500 shares of VINC for 0.95 per share on Aug 11 ’23. After the transaction, the insider now owns 30,280 company shares. In a previous transaction on Aug 10 ’23, Hamdy Ahmed MD bought 5,400 shares at 0.96 per share. VINC shares that the insider owns now total 96,060.

Among the insiders who bought shares, THOMAS TOM C acquired of 5,000 shares on Aug 10 ’23 at a per-share price of $0.95. This resulted in the insider holding 219,935 shares of VINC after the transaction. In another insider transaction, Izumi Raquel E. bought 3,440 shares at $0.93 per share on Aug 10 ’23. Company shares held by the insider now total 85,214.

Even though price targets are rarely accurate, they do tend to exert some kind of influence from time to time and are often considered important by markets. In terms of 52-week highs and lows, VINC has a high of $9.37 and a low of $0.61.

As of this writing, VINC has an earnings estimate of -$0.22 per share for the current quarter. EPS was calculated based on a consensus of 2 estimates, with a high estimate of -$0.19 per share and a lower estimate of -$0.26.

Balance Sheet Annually/Quarterly

In a balance sheet, you can see what assets and liabilities the company has, as well as how much equity investors have invested. These figures can be used to calculate a company’s financial ratios to give investors a better idea of its prospects. VINC’s latest balance sheet shows that the firm has $111.46M in Cash & Short Term Investments as of fiscal 2021. There were $4.17M in debt and $13.92M in liabilities at the time. Its Book Value Per Share was $0.52, while its Total Shareholder’s Equity was $100.32M.

Analysts Opinion

The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for VINC is Buy with a score of 5.00.

Most Popular

Related Posts